{
    "form.title": "Certificate of Supplementary Protection (CSP) Application Form",
    "version": "Version ",
    "top.fromHC": "From <a href='https://www.canada.ca/en/health-canada.html'>Health Canada</a>",
    "top.privacy.statement": "Privacy Notice Statement",
    "top.security.declaimer": "Security Disclaimer",
    "top.instruction": "Instructions",
    "toc.form": "Form",
    "instruction.help": "Instructions for completing sections on form",
    "load.file": "Load a Saved Certificate of Supplementary Protection Application File",
    "select.file": "Select a file to load",
    "choose.file":"Choose File",
    "no.file.chosen": "No file chosen",
    "refresh.file.input": "Refresh this page",
    "add.transaction": "New Record",
    "sequence.num": "Sequence Number",
    "new": "NEW",
    "existing": "EXISTING",
    "date.submitted": "Date Submitted (YYYY-MM-DD)",
    "sequence.descript": "Regulatory Transaction Description",
    "is.actchanges": "Same as Regulatory Activity Contact for this Submission?",
    "is.ectd": "Is this an eCTD transaction?",
    "is.solicited": "Is this solicited information?",
    "solicited.rq": "Requester of Solicited Information",
    "solicited.rq.other": "Other Requester Details",
    "rep.contact.info": "Main Contact Information",
    "proj.manager.name": "Name of Regulatory Project Manager, if known",
    "dated": "Dated (YYYY-MM-DD)",
    "start.date": "Start Date (YYYY-MM-DD)",
    "end.date": "End Date (YYYY-MM-DD)",
    "reg.activity": "Regulatory Activity",
    "reg.activity.type": "Regulatory Activity Type",
    "sequence.type": "Regulatory Transaction Description",
    "version.no": "Version Number",
    "brief.desc": "Brief Description",
    "brief.desc.change": "Brief Description of change",
    "administrative": "Administrative",
    "benefit.risk.assess": "Benefit Risk Assessment",
    "blood.est": "Blood Establishment",
    "cancel.letter": "Cancellation Letter",
    "change.to.din": "Change to DIN",
    "comments.noc": "Comments on Notice of Decision",
    "comments.summary.basis": "Comments on Summary Basis of Decision (SBD)",
    "comments.regulartory.decision": "Comments on Regulatory Decision Summary",
    "din.discontinued": "Discontinuation of Sale Notification",
    "drug.notif.form": "Drug Notification Form (Market Notification)",
    "for.period": "For Period of",
    "for.noc": "For NOC/c products",
    "final.risk.com": "Final Risk Communication Document",
    "immediate.notification": "Immediate Notification",
    "initial": "INITIAL",
    "meeting.minutes": "Minutes of Meeting",
    "notification.change": "Notification of Change in Benefit-Risk Profile",
    "notification.interrupt.sale": "Notification for Interruption of Sale (DIN Dormant)",
    "pandemic.appl": "Pandemic Application",
    "post.clearance.data": "Post Clearance Data",
    "post.market.surv": "Post-Market Surveillance",
    "post.noc.change": "Post NOC Change",
    "post.auth.div1.change": "Post-Authorization Division 1 Change",
    "presub.meeting.pkg": "Submission Meeting Package",
    "presub.meeting.rq": "Submission Meeting Request",
    "priority.review.rq": "Priority Review Request",
    "product.labelling.post.approval": "Product Labelling - Post Approval",
    "pristine.pm": "Pristine PM",
    "second.lang.pm": "Second Language PM",
    "pristine.pm.2lang": "Second Language PM and Final Package Insert",
    "clin.clarif.response": "Response to Clinical Clarification Request",
    "email.rq.response": "Response to E-mail Request",
    "hsc.rq.response": "Response to Human Safety Clarification Request",
    "qhsc.rq.response": "Response to Quality & Human Safety Clarification Request",
    "chsc.rq.response": "Response to Clinical & Human Safety Clarification Request",
    "qchsc.rq.response": "Response to Quality, Clinical and Human Safety Clarification Request",
    "label.clarif.response": "Response to Labelling Clarification Request",
    "mhpd.rq.response": "Response to MHPD Letter",
    "noc.response": "Response to NOC/c-QN",
    "nod.response": "Response to NOD",
    "non.response": "Response to NON",
    "nol.response": "Response to NOL",
    "processing.clarif.response": "Response to Processing Clarification Request",
    "qual.clin.clarif.response": "Response to Quality & Clinical Clarification Request",
    "qual.clarif.response": "Response to Quality Clarification Request",
    "screening.accept.response": "Response to Screening Acceptance Letter",
    "screening.clarif.response": "Response to Screening Clarification Request",
    "sdn.response": "Response to SDN",
    "phone.rq.response": "Response to Telephone Request",
    "risk.commun.doc": "Risk Communication Document",
    "rmp.version.date": "Risk Management Plan (RMP)",
    "signal.work.up": "Signal Work Up",
    "unsolicited.data": "Unsolicited Information",
    "year.list.of.change": "Year(s) of change, list of change number(s) ",
    "nonclin.clarif.response": "Response to Non-clinical Clarification Request ",
    "be.clarif.response": "Response to BE Clarification Request",
    "recon.decis.ltr.intent": "Reconsideration of Decision - Letter of Intent",
    "recon.decis.rq.recon": "Reconsideration of Decision - Request for Reconsideration",
    "recon.decis.other.info": "Reconsideration of Decision - Other Information",
    "label.preapproval.2lang": "Second Language Label - Pre-Approval",
    "post.anth.change": "Post Authorization Change",
    "rolling.info": "Rolling Information",
    "protocol.review": "Protocol Review",
    "lifecycle.title": "Transaction Details",
    "reg.contact.this": "Contact for THIS Regulatory Activity",
    "reg.act.contact": "Regulatory Activity Contact",
    "transaction.hding": "Regulatory Information",
    "load.transaction": "Load a Regulatory Transaction File",
    "company.info": "A. Company Information",
    "address.info": "B. Address Information",
    "company.rep.this": "Company Representative",
    "generate.final": "Generate Final XML",
    "confirm.contact.valid": "I confirm that the above regulatory activity contact information is valid.",
    "year.change": "Year(s) of change, list of change number(s)",
    "years": "Year",
    "clarif.response": "Response to Clarification Request",
    "corr.patent.med": "Correspondence - Patented Medicines",
    "allegation.notice": "Notice of Allegation",
    "form.iv": "Form IV",
    "form.v": "Form V",
    "consent.ltr": "Consent Letter",
    "data.protect.corresp": "Correspondence - Data Protection",
    "choose.request": "Choose a requester",
    "list.descript": "List Description",
    "adv.comp.req": "Advertising Complaint Request for Information",
    "csotrmp": "Canadian Specific Opioid RMP",
    "dissem.list": "Dissemination List",
    "foreign.safety.notification": "Foreign Safety Action Notification",
    "issue.safety.request": "Issue Related Summary Report Request",
    "patient.safety.info": "Patient Safety Information (Medication error)",
    "pub.release.info": "Public Release of Clinical Information",
    "ressess.order": "Reassessment Order",
    "written.consult.req": "Request for Written Consultation",
    "test.studies.order": "Test and Studies Order",
    "term.cond.comm": "Terms and Conditions Commitment",
    "year": "Year",
    "ctn.administrative": "CTN-Administrative Change to",
    "ctn.appendix": "CTN-Appendix",
    "ctn.contact": "CTN-Contact Change",
    "ctn.cross": "CTN-Cross Reference Letter",
    "ctn.data": "CTN-Data Safety Monitoring Committee",
    "ctn.dear": "CTN-Dear Investigator/Doctor Letter",
    "ctn.diluent": "CTN-Diluent Change",
    "ctn.drug.prod": "CTN-Drug Product Change",
    "ctn.drug.subs": "CTN-Drug Substance change",
    "ctn.enrollment": "CTN-Enrollment Suspension",
    "ctn.ethics": "CTN-Ethics Board Communications",
    "ctn.exclusion.inclusion": "CTN-Exclusion/Inclusion Criteria Revision",
    "ctn.informed": "CTN-Informed Consent Form Update",
    "ctn.investigator": "CTN-Investigator\u2019s Brochure Update",
    "ctn.new.manufacturing": "CTN-New Manufacturing Site for",
    "ctn.new.pkg": "CTN-New Packaging/Labelling Site",
    "ctn.new.qc": "CTN-New QC Testing Site",
    "ctn.nol": "CTN-NOL Response",
    "ctn.packaging.labelling": "CTN-Packaging/Labelling Name Change",
    "ctn.pm": "CTN-PM Update",
    "ctn.protocol.info.update": "CTN-Protocol and Informed Consent Form Update",
    "ctn.protocol.update": "CTN-Protocol Update/Change",
    "ctn.qos": "CTN-QOS Update",
    "ctn.refusals": "CTN-Refusals by Foreign Regulatory Authorities/REBs",
    "ctn.regulatory": "CTN-Regulatory Hold",
    "ctn.response": "CTN-Response to Information Request",
    "ctn.safety": "CTN-Safety Update",
    "ctn.shelf.pd": "CTN-Shelf Life Extension for DP",
    "ctn.shelf.ds": "CTN-Shelf Life Extension for DS",
    "ctn.site": "CTN-Site Closure",
    "ctn.source": "CTN-Source Change of",
    "ctn.strain": "CTN-Strain Change",
    "ctn.study.completion": "CTN-Study Completion",
    "ctn.study.disc": "CTN-Study Discontinuation due to",
    "ctn.study.ext": "CTN-Study Recruitment Timeline Extension",
    "ctn.study.sus": "CTN-Study Suspension",
    "ctn.trans.own": "CTN-Transfer of Ownership",
    "ctn.form.broc.updates": "CTN-Informed Consent Form and Investigator\u2019s Brochure Updates",
    "ctn.impd.update": "CTN-IMPD Update",
    "ctn.new.summ.adf": "CTN-New Summary of Additional Drugs Form",
    "clinical": "CLINICAL",
    "clinical.quality": "CLINICAL & QUALITY",
    "quality": "QUALITY",
    "initial.teat.solu.mono": "INITIAL - Teat Solutions Monograph",
    "req.accepted": "Request Accepted",
    "snd.lang.pm": "Second Language PM",
    "requester.name": "Name of requester",
    "requester.name2": "Name of requester 2",
    "requester.name3": "Name of requester 3",
    "defer.fees": " A deferral of payment is requested with this transaction.",
    "defer.statement": "The statement supporting the deferral request is included.",
    "fee.remission": "Fee Remission is requested with this transaction",
    "statement.revenue": "A statement signed by the individual responsible for the applicant's financial affairs is included to certify that the fee payable is greater than 10% of the anticipated gross revenue",
    "sub.class": "Submission Class",
    "fee.amount": "Fees",
    "fee.description": "Submission Description",
    "remission.eligible": "You are eligible to apply for fee remission. The submission fee is greater than 10% of anticipated gross revenues.",
    "remission.ineligible": "You are not eligible to apply for fee remission. The submission fee is less than 10% of anticipated gross revenues.",
    "is.fee.transaction": "Are new or revised fees associated with this transaction? Please identify fees when applying for remission.",
    "regulatory.fees": "Fees",
    "gross.revenue": "Anticipated gross revenue for this drug product during the fee verification period",
    "ten.percent.revenue": "10% of anticipated gross revenue",
    "required.doc": "Required Documentation",
    "supporting.doc": "Please include the required signed statement AND at least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period.",
    "est.market.share": "Estimated market share (that is [i.e.], product's market potential compared to the total market for similar products in Canada)",
    "similar.product": "Comparison to similar products on the Canadian market or other similar markets (e.g., United States, European Union)",
    "sales.history": "Sales history prior to product upgrades or sales history of similar products",
    "marketing.plan": "Marketing plan/product plan for the drug product",
    "avg.sales": "Average sale price and demand",
    "fees.less10k": "Fees of $10,000 or less must be paid at the time of filing of the submission, supplement or application. Please complete the",
    "advance.payment": "Advance Payment Details for Drug Submissions and Master Files.",
    "sponsor.invoice": "Review fees must not be included with the submission, supplement or application. Sponsors will be invoiced for fees of more than $10,000.",
    "payment.methods": "Please select all the payment methods you intend to use",
    "one.payment.method": "Please select all the payment methods you intend to use",
    "one.fee.doc": "At least one of the support documentation to establish that the applicable fee payable is greater than 10% of the anticipated gross revenue from sales of the drug product in Canada during the fee verification period",
    "please.remit": "Please pay the remission processing fee of $590 using the Advance Payment Details for Drug Submissions and Master Files.",
    "apply.defer": "You are applying for a deferral. Please send no payment with this form.",
    "bank.draft": "International Bank Draft",
    "money.order": "Money Order",
    "cheque": "Cheque",
    "payment": "Payment",
    "credit": "MasterCard/Visa/American Express (AMEX)",
    "bank.wire": "Wire (include bank confirmation)",
    "existing.credit": "Existing credit",
    "prefeered.option": "Bill Payment Service Option (preferred method)",
    "reg.transact": "Regulatory Transaction",
    "life.rec": "Transaction Details Record",
    "oneliferec": "One transaction details record is required.",
    "saveliferec": "One transaction details record is required to save.",
    "lifecyclectrl.lifecycledetailsform": "with a Transaction Details Record",
    "is.new.activity": "Is this transaction for a new or existing regulatory activity?",
    "is.signed.3rd.party": "Is the contact for this regulatory activity a third party corresponding on behalf of the manufacturer/sponsor?",
    "aut.letter.note": "A signed third party authorization form is required for regulatory activities listed on the form. Refer to the list in the notes/requirements section of the form posted on Health Canada's website.",
    "is.priority": "Was this regulatory activity approved for priority review?",
    "is.noc": "Was this regulatory activity approved for NOC/C review?",
    "is.admin.submission": "Is this an Administrative Submission or Application?",
    "admin.descript": "Administrative Submission or administrative component description",
    "admin.sub.type": "Reason for Administrative Submission or Application",
    "activity.lead": "Regulatory Activity Lead",
    "other.doc.details": "Other Documentation Details",
    "b14-20160301-09": "Pharmaceutical",
    "b14-20160301-02": "Biological",
    "b14-20160301-10": "Post-Market Vigilance (for Marketed Health Products Directorate (MHPD))",
    "b14-20160301-06": "Consumer Health Product",
    "b14-20160301-11": "Veterinary",
    "b14-20160301-04": "Clinical Trial - Biologics",
    "b14-20160301-05": "Clinical Trial - Pharmaceutical",
    "reset": "RESET",
    "reset.info": "To enable the 'generate final XML' button, select the 'RESET' button to clear transaction specific fields.",
    "fee.remit.no.payment": "Please remit no payment with this transaction. Payment of the fees will be required upon issuance of an invoice",
    "mitigation.type": "The following mitigation measures are available (select one). Sponsors must certify that they meet the criteria as outlined in the Food and Drug Regulations.",
    "certify.organization": "We certify that we meet the definition of small business and have registered our company with Health Canada prior to submitting this submission/application. We understand that failure to register as a small business prior to submitting this submission/application will result in the full fee being charged.",
    "certify.organization.a": "a total number of employees less than 100 people, or",
    "certify.organization.b": "a total annual gross revenue between $30,000 and $5 million.",
    "small.business.fee.application": "We have not previously filed a submission/application in respect of a drug with Health Canada. We are filing our first submission/application.",
    "first.submission": "This is my first submission/application",
    "certify.goverment.organization": "We certify that our organization is a branch or agency of the Government of Canada or of a province or territory",
    "certify.urgent.health.need": "We certify that the drug in our submission/application is on the List of Drugs for an Urgent Public Health Need as per the Access to Drugs in Exceptional Circumstances Regulations AND",
    "drug.the.same.ingredient": "the drug has the same medicinal ingredient, strength and route of administration, and is in a comparable dosage form, as a drug that may be imported under subsection C.10.001(2) of those Regulations;",
    "no.drug.identification.number": "no drug identification number has been assigned under section C.01.014.2 of those Regulations for the drug or for another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form; and",
    "no.notice.compliance": "no notice of compliance has been issued under section C.08.004 of those Regulations in respect of the drug or another drug that has the same medicinal ingredient, strength and route of administration and is in a comparable dosage form.",
    "certify.funded.health.institution": "We certify that our institution is funded by the Government of Canada or the government of a province or territory and that it is",
    "certify.funded.health.institution.a": "licensed, approved or designated by a province in accordance with the laws of the province to provide care or treatment to persons or animals suffering from any form of disease or illness; or",
    "certify.funded.health.institution.b": "owned or operated by the Government of Canada or the government of a province and that provides health services.",
    "certify.isad": "We certify that we have filed an application for a designated COVID-19 drug under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (ISAD), and that a submission has not previously been filed seeking approval for that same drug",
    "type.min": "End Date should not be earlier than Start Date.",
    "fee.pay.notice": "Do not send fee payment with your submission, supplement or application. Health Canada will verify the fee and issue an invoice accordingly. For information on payment of invoices and current fees, please visit",
    "fees.and.funding.rev": "the Fees and Funding webpage",
    "fees.and.funding.url": "https://www.canada.ca/en/health-canada/services/drugs-health-products/funding-fees.html",
    "mitigation.measures": "Mitigation Measures",
    "prod.protocol": "Protocol Number",
    "cta.from": "From [time]",
    "cta.to": "To [time]",
    "covir-19": "COVID-19 Interim Order Application",
    "covir-19amd": "COVID-19 Interim Order Ap - Amendment",
    "reg.activity.lead.desc": "Regulatory Activity Lead Description",
    "activity.lead.pha": "Pharmaceutical: Includes all regulatory activities and transactions for prescription pharmaceuticals and ethical products under the Pharmaceutical Drugs Directorate (PDD) mandate. This lead is not applicable for non-prescription pharmaceutical or disinfectant products or post-market vigilance regulatory activities.",
    "activity.lead.bio": "Biological: Includes all regulatory activities and transactions under the Biologics and Radiopharmaceutical Drugs Directorate (BRDD) mandate (biologics/radiopharmaceuticals).",
    "activity.lead.pmv": "Post-Market Vigilance: Includes all regulatory activities and transactions under the Marketed Health Products Directorate (MHPD) mandate (prescription and non-prescription pharmaceuticals for human use, biologics, radiopharmaceuticals).",
    "activity.lead.chp": "Consumer Health Products: Includes all regulatory activities and transactions for non-prescription pharmaceuticals and disinfectants under the Natural and Non-Prescription Health Products Directorate (NNHPD) mandate.",
    "activity.lead.vet": "Veterinary: Includes all regulatory activities and transactions for prescription and non-prescription pharmaceuticals under the Veterinary Drugs Directorate (VDD) mandate.",

    "notice.apr.2020": "Important Note: This template includes the revised Fees effective April 1, 2020 and should be used for regulatory transactions intended for filing on or AFTER April 1, 2020.",
    "ra.type.note.udra": "If your transaction description does not fit any category of listed transaction descriptions, contact the appropriate directorate at Health Canada via email: <br /> For biologics and radiopharmaceuticals for human use: <a href='mailto:brdd.ora@hc-sc.gc.ca'>brdd.ora@hc-sc.gc.ca</a> <br /> For pharmaceuticals for human use: <a href='mailto:rpmd-dgpr@hc-sc.gc.ca'>rpmd-dgpr@hc-sc.gc.ca</a> <br> For non-prescriptions and disinfectants: <a href='mailto:rpmd-dgpr@hc-sc.gc.ca'>nded-demvso@hc-sc.gc.ca</a>",
    "ra.type.note.l3noc": "There is no control number associated with this regulatory activity",
    "ra.type.note.nc": "Fees are not applicable to this regulatory activity type (for human biologic or radiopharmaceutical drug quality changes)",
    "ra.type.note.din": "Refer to Drug Identification Number (DIN) Guidance Document",
    "ra.type.note.pdc": "Fees are not applicable to this regulatory activity type",
    "ra.type.note.pdinn": "Should not be used for Drug Notification Forms.",
    "initial.descr": "First transaction of the new regulatory activity for a product that does not have an existing DIN.",
    "pandemic.appl.descr": "First transaction of a new regulatory activity.",
    "post.anth.change.descr": "First transaction of a new regulatory activity.",
    "post.noc.div1.change.descr": "First transaction of a new regulatory activity.",
    "post.clearance.data.descr": "Transactions related to an already cleared regulatory activity with existing control number. This is not applicable to transactions related to post-market vigilance regulatory activities.",
    "post.noc.change.descr": "First transaction of a new regulatory activity.",
    "processing.clarif.response.descr": "Response to Health Canada clarification request during processing.",
    "rolling.info.descr": "For subsequent transaction containing information identified as part of the plan.",
    "change.to.din.descr": "First transaction of a new regulatory activity for a product that already has an existing DIN.",
    "cancel.letter.descr": "Transaction to officially withdraw the regulatory activity.",
    "admin.descr": "First transaction of a new regulatory activity for an administrative change according to the Guidance Document: ",
    "admin.descr.link.label": "Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs",
    "admin.descr.url": "https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/administrative-processing-human-disinfectant-drugs-2019/document.html",
    "meeting.minutes.descr": "Transaction to provide minutes from a pre-submission meeting.",
    "screening.clarif.response.descr": "Response to Health Canada clarification request during screening.",
    "presub.meeting.rq.descr": "Transaction to request a pre-submission meeting.",
    "unsolicited.data.descr": "See \u201cunsolicited information\u201d section of the Guidance Document: Management of Drug Submissions and Applications.",
    "refer.to.guide.doc": "Refer to the Guidance Document: ",
    "admin.guide.doc": "Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs.",
    "admin.guide.doc.url": "https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/administrative-processing-human-disinfectant-drugs-2019/document.html",
    "admin.guide.doc.note": "Note: The administrative fee class should be selected.",
    "admin.guide.doc.note2": "The Transaction description \u201cAdministrative\u201d should be used for the first transaction for this regulatory activity.",
    "withdrawal.nof.form": "Withdrawal of Drug Notification Form",
    "advisement.letter.response": "Response to Advisement Letter to update the Product Monograph",
    "nof.drug.short": "Notification on Drug Shortage",
    "quality.issu": "Quality issue raised by company and/or other regulator",
    "gmp.comp.issu": "GMP compliance issue raised by other regulators",
    "reclass.lot.release": "Reclassification request under BRDD Lot Release Program",
    "noc.compliance": "Notice of Compliance with Conditions (NOC/c) \u2013 commitment",
    "udra.cancel.letter": "Cancellation Letter for UDRA",
    "udra.meeting.minutes": "Minutes of Meeting for UDRA",
    "udra.email.rq.response": "Response to E-mail Request for UDRA",
    "udra.processing.clarif.response": "Response to Processing Clarification Request for UDRA",
    "gen.vol.nof": "General / Voluntary Notification",
    "advisement.letter.response.descr": "When providing rationale to not incorporate changes requested via advisement letter. ",
    "nof.drug.short.descr": "When notifying Health Canada about a drug shortage, including a request for Special Lot Release related to the drug shortage.",
    "quality.issu.descr": "When notifying Health Canada about quality related issues (example: Notification of an Out-Of-Specification (OOS) results).",
    "gmp.comp.issu.descr": "When notifying Health Canada about issues/concerns with media fill failures, sterility, violation of GMPs, out of specifications results (example: failure of appearance test due to visible particles), potency assay, stability, etc. which are not subject to submission filing.",
    "reclass.lot.release.descr": "When submitting outside of a regulatory activity.",
    "noc.compliance.descr": "When submitting information to Health Canada as per the Guidance Document: <a href='https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-compliance-conditions.html'>Notice of Compliance with Conditions (NOC/c)</a>: <ul> <li> Annual Progress Report of Confirmatory Trials </li> <li> Rationale for re-negotiation of NOC/c commitment(s)</li></ul> ",
    "udra.cancel.letter.descr": "Transaction to officially withdraw a submitted UDRA. Verify DSTS-IA for the correct control number. ",
    "udra.meeting.minutes.descr": "Transaction to provide minutes from a meeting that was conducted regarding a filed UDRA. Verify DSTS-IA for the correct control number.",
    "udra.email.rq.response.descr": "Response to Health Canada clarification request related to an UDRA. Verify DSTS-IA for the correct control number. Provide Health Canada issued correspondence.",
    "udra.processing.clarif.response.descr": "Response to Health Canada clarification request during processing of the UDRA by Office of Submissions and Intellectual Property. Provide Health Canada issued correspondence.",
    "gen.vol.nof.descr": "Contact Health Canada via email prior to using this regulatory transaction description. <br> For biologics and radiopharmaceuticals for human use: <a href='mailto:brdd.ora@hc-sc.gc.ca'>brdd.ora@hc-sc.gc.ca</a> <br> For pharmaceuticals for human use: <a href='mailto:rpmd-dgpr@hc-sc.gc.ca'>rpmd-dgpr@hc-sc.gc.ca</a> <br> For non-prescriptions and disinfectants: <a href='mailto:nded-demvso@hc-sc.gc.ca'>nded-demvso@hc-sc.gc.ca</a>",
    "din.discontinued.descr": "When reporting that the sale of the product (DIN) has been discontinued including discontinuation date, lot number and expiry date of the last lot distributed. DIN will be canceled by Health Canada",
    "notification.interrupt.sale.descr": "When reporting that the product (DIN) has not been sold for twelve consecutive months",
    "post.market.surv.descr": "Examples include: Unsolicited submission of stand-alone elements of an RMP such as updates to protocol and results of post-approval studies, educational materials; proposals for change in frequency of PSUR/PBRER submission; proposals for discontinuation of continued monitoring strategies; plans for risk mitigation activities in other jurisdictions; and EU/PRAC assessments. <br> For the submission of information requested by MHPD, use 'Response to MHPD Letter'.",
    "mhpd.rq.letter.descr": "Response to MHPD Letter following review of post-authorization scientific review. Respond as directed within the MHPD correspondence.",
    "benefit.risk.assess.descr": "Response to HC request for a benefit-risk assessment made to MAH either voluntarily or under section 21.31 of the Food and Drugs Act, or sections C.01.052 and C.01.013 of the Food and Drugs Regulations.",
    "notification.change.descr": "Notification to Minister that there has been a significant change in what is known about the benefit\u2014risk profile of the drug, as required under C.01.018 (4) of the Food and Drug Regulations.",
    "test.studies.order.descr": "Response to Order by HC as requested under section 21.32 of the Food and Drugs Act.",
    "issue.safety.request.descr": "Response to Health Canada's request to submit an Issue-Related Summary Report under C.01.019 of the Food and Drug Regulations.",
    "foreign.safety.notification.descr": "Submitted as required under Section C.01.050 of the Food and Drug Regulations.",
    "risk.commun.doc.descr": "First draft of the Health Product Risk Communication (HPRC) in Word format.",
    "final.risk.com.descr": "Health Product Risk Communication (HPRC) final versions in English and French and in Word and PDF format.",
    "dissem.list.descr": "Dissemination strategy and dissemination results.",
    "patient.safety.info.descr": "Response to Health Canada's request to provide information  or changes as oulined in the MHPD letter. Examples of these requests could be additional information,  additional monitoring, label changes, etc.",
    "immediate.notification.descr": "Immediate Notifications are for minor changes where timely awareness is necessary. Health Canada should be notified within the time window extending from 21 days before and 14 days after the implementation date. This reporting category also includes the majority of major and moderate changes that have been downgraded to minor quality changes as a result of the execution of a PACMP or through a negotiated EC and associated reporting category.",
    "ra.type.note.euands": "Health Canada will not invoice fees for Extraordinary Use New Drugs filed under C.08.002.1 of the Food and Drug Regulations (FDR), however please ensure the applicable submission class is selected in the fee section below.",
    "ra.type.note.eunds": "Health Canada will not invoice fees for Extraordinary Use New Drugs filed under C.08.002.1 of the Food and Drug Regulations (FDR), however please ensure the applicable submission class is selected in the fee section below.",
    "ra.type.note.eusands": "Health Canada will not invoice fees for Extraordinary Use New Drugs filed under C.08.002.1 of the Food and Drug Regulations (FDR), however please ensure the applicable submission class is selected in the fee section below.",
    "ra.type.note.eusnds": "Health Canada will not invoice fees for Extraordinary Use New Drugs filed under C.08.002.1 of the Food and Drug Regulations (FDR), however please ensure the applicable submission class is selected in the fee section below.",
    "ra.type.note.psurpv": "For NOC/c products",
    "rq.review.report": "Request Review Report(s)",
    "5digits.only": " (5 digits only)",
    "commmon.required.bracket": " (required)",
    "enrolVersion":"Enrolment Version",
    "dateLastSaved":"Date Last Saved",
    "patent.Id":"Canadian Patent Number",
    "filling.date":"Patent Filing Date",
    "grand.date":"Patent Date Granted",
    "expiration.date":"Patent Expiration Date",
    "panel.title.csp":"Certificate of Supplementary Protection (CSP) Information",
    "panel.title.applicant":"1. Applicant Information",
    "panel.title.patent":"2. Patent Information",
    "panel.title.druguse":"5. Drug Use",
    "drug.use":"Drug Use",
    "panel.title.noticeofcompliance":"4. Notice of Compliance (NOC) Date",
    "noc.date":"NOC Date",
    "required": "This field is required",
    "error": "Error {{number}}:",
    "errorSummary.cspfile": "Certificate of Supplementary Protection (CSP) Application Form",
    "error.found.because": " could not be saved because ",
    "error.found.plural": " errors were found",
    "error.found.singular": " error was found",
    "new.drug.submission.info.nds.number": "NDS Number",
    "panel.title.new.drug.submission.info": "3. New Drug Submission (NDS) Information",
    "medicinal.ingredients": "Medicinal ingredient(s) (as provided on the NOC for the NDS provided in Section 3)",
    "product.name": "Product Name (as provided on the NOC for the NDS provided in Section 3)",
    "panel.title.medicinal.ingredients": "7. Medicinal Ingredient(s)",
    "panel.product.name": "Product Name",
    "applicant.name":"Applicant Name",
    "cra.business.number":"CRA Business Number",
    "csp.customer.number":"CSP Customer Number",
    "agent.name":"Agent Name (Full legal Name - no abbreviations)",
    "panel.title.timing.of.application": "6. Timing of Application",
    "application.is.applying":"Application is applying(select one only)",

    "panel.title.attestations": "8. Attestations",
    "attestation.as.applicant": "Attestation as to Applicant",
    "attestation.timely.submission": "Attestation as to Timely Submission",

    "panel.title.fees": "9. Fee Payment",
    "fees.text": "This electronic form <b>should not</b> include payment information (e.g. credit card number), as the information included within an electronic form cannot be deleted and will remain a part of the CSP application on record.",
    "fees.paid": "The fee has been paid in the amount of (please enter the fee amount)",
    "pay.method": "Method of Payment",
    "section.show": " [ This section may not be visible. ]",

    "applicant.contact.info":"Applicant Contact Information (where all communications regarding the CSP will be sent)",
    "addressDetails.street": "Street address",
    "addressDetails.city": "City or town",
    "addressDetails.country": "Country",
    "addressDetails.province": "Province",
    "addressDetails.state": "State",
    "addressDetails.postalZipCode":"Postal/ZIP code (Use \"not applicable\" if not available)",
    "addressDetails.postalCode": "Postal code",
    "addressDetails.zipCode": "Zip code",
    "addressDetails.provState": "Province or state",
    "first.name":"First name",
    "initials":"Initials",
    "last.name":"Last name",
    "lang.correspond":"Language of correspondence",
    "job.title":"Job title",
    "phone.number":"Phone number (including area code)",
    "phone.extension":"Phone extension",
    "fax.number":"Fax number (including area code)",
    "fax.number.nofaxnum": "(Use 0000000000 if not available)",
    "contact.email":"Email",
    "error.msg.minlength": "Invalid entry - must be {{ requiredLength }} numbers",
    "error.mgs.dossier.id": "Incorrect format - The dossier identifier is incorrect for this dossier type. Please verify the dossier identifer and dossier type for your product.",
    "error.msg.zip":"Invalid entry - must be 5 numbers",
    "error.msg.postal":"Invalid format - must be X#X#X#",
    "error.msg.email":"Invalid format - Must be xxxx@xxxx.xxx",
    "error.msg.invalidDate": "The date is not valid",

    "panel.title.hc.only": "Health Canada Use Only",
    "hco.app.received": "Date Application Received",
    "hco.cust.num": "CSP Customer Number",
    "hco.app.num": "CSP Application Number",
    "hco.notes": "Notes",

    "panel.title.certification": "10. Certification",
    "cert.name": "Name of Authorized Official",
    "cert.first": "First Name",
    "cert.initials": "Initials",
    "cert.last": "Last Name",
    "cert.job": "Job Title",
    "cert.date": "Date",

    "ht.load.1": "Files to load",
    "ht.load.2": "Working Copy (.hcsc) – when continuing with an incomplete application form.",
    "ht.load.3": "Final XML – when amending a final application form.",
    "ht.load.4": "A file should not be loaded if it is the initial form.",
    "ht.date.1": "Certificate of Supplementary Protection (CSP) Information",
    "ht.date.2": "The <b>“Enrolment Version”</b>, and <b>“Date Last Saved”</b> fields are automatically filled by the form upon selecting <b>“Save Working Copy”</b> or <b>“Save Draft for Filing”</b> in the bottom of the template.",
    "ht.app.1": "Applicant Contact Information",
    "ht.app.2": "<b>Applicant Name:</b> Enter the name of the applicant making the CSP application. See section 2.2.2 of the Guidance Document: Certificates of Supplementary Protection for information on the Attestation as to applicant.",
    "ht.app.3": "<b>CRA Business Number:</b> Provide the nine-digit number that the Canada Revenue Agency has assigned to the applicant.",
    "ht.app.4": "<b>CSP Customer Number:</b> Provide the applicant’s CSP Customer Number. Please contact the Office of Patented Medicines and Liaison in advance of a CSP application filing deadline in order to obtain a CSP Customer Number or to confirm an existing CSP Customer Number, if it is not known.",
    "ht.app.5": "<b>Agent name:</b> Provide the name of the organization or person with the authority to correspond with Health Canada regarding the CSP application. Any organization or person having contact information in Canada may be named as the agent. If you are providing an agent name, then all contact information must be the agent’s contact information, except for the CSP Customer Number, which is unique to the applicant. If you wish to use the applicant’s contact information, then please do not include an agent name on this application form even if you are using an agent.",
    "ht.app.6": "<b>Names:</b> Provide the name of a person with the authority to correspond with Health Canada on behalf of the applicant making the CSP application.",
    "ht.app.7": "<b>Job Title:</b> Enter the job title of the person named.",
    "ht.app.8": "<b>Address (Street/Suite, City, Province, and Postal Code):</b> Include the address in Canada at which the person named is located for purposes of the business of the applicant.",
    "ht.app.9": "<b>Telephone Number, Facsimile Number, and E-mail:</b> Provide the telephone and facsimile number and e-mail address of the person named whom may be contacted by Health Canada regarding the CSP application. This information will be used to contact the applicant regarding any issues with respect to the CSP application. Health Canada issues CSPs by sending an electronic certificate by e-fax to the facsimile number provided.",
    "ht.bill.add.1": "<b>Billing Address:</b> Check the box, if applicable, to indicate that a different billing address will be used. The billing address will only be contacted should there be any issues with respect to the fee payment. Please note that an agent with multiple CSP applications may only have one billing address at any given time in respect of its CSP applications. The address may be updated, however multiple billing addresses are not permitted concurrently.",
    "ht.bill.add.2": "<b>Organization Name:</b> Provide the name of the organization with the authority to correspond with Health Canada regarding billing matters in the CSP application.",
    "ht.bill.add.3": "<b>Names:</b> Provide the name of the person with the authority to correspond with Health Canada on behalf of the applicant with respect to billing matters in the CSP application.",
    "ht.bill.add.4": "<b>Job Title:</b> Enter the job title of the person named with respect to billing matters.",
    "ht.bill.add.5": "<b>Address (Street / Suite, City, Province, Country, and Postal Code):</b> Include the address at which the person named is located for the purpose of addressing billing matters in the CSP application.",
    "ht.bill.add.6": "<b>Telephone Number, Facsimile Number, and E-mail:</b> Provide the telephone and facsimile number and e-mail address, of the person named whom may be contacted by Health Canada regarding the billing matters for the CSP application. This contact information will be used to address any issues with the CSP application with respect to billing matters in the CSP application.",
    "ht.patent.1": "Patent Information",
    "ht.patent.2": "<b>Canadian Patent Number:</b> Provide the Canadian patent number in relation to which the certificate is sought. One CSP application is required for each patent number.",
    "ht.patent.3": "<b>Patent Filing Date:</b> Indicate the Canadian patent application filing date. The filing date of the patent must be on or after October 1, 1989 according to paragraph 106(1)(b) of the Patent Act.",
    "ht.patent.4": "<b>Patent Date Granted:</b> Enter the date on which the patent was granted by the Canadian Intellectual Property Office.",
    "ht.patent.5": "<b>Patent Expiration Date:</b> Enter the date on which the patent term will expire.",
    "ht.drug.1": "New Drug Submission (NDS) Information",
    "ht.drug.2": "<b>New Drug Submission:</b> Enter the NDS number listed on the Notice of Compliance (NOC) that was issued with respect to the medicinal ingredient or combination of medicinal ingredients; the NOC must meet the requirements set out in paragraphs 106(1)(c) and (d) of the Patent Act. According to paragraph 106(1)(d) of the Patent Act, the NOC must be the first authorization for sale that has been issued in Canada with respect to the medicinal ingredient or the combination of medicinal ingredients, as the case may be. According to paragraph 106(1)(c) of the Patent Act, the NOC issuance date must be on or after September 21, 2017. The NDS must also have been filed in accordance with the timely submission requirement outlined in paragraph 106(1)(f) of the Patent Act.",
    "ht.noc.1": "Notice of Compliance (NOC) Date",
    "ht.noc.2": "<b>Notice of Compliance Date:</b> Enter the date that appears on the NOC issued for the NDS that is set out in the CSP application. Applicants may view this information on Health Canada's online NOC database, or they may request a copy of the NOC from Health Canada.",
    "ht.drug.use.1": "Drug Use",
    "ht.drug.use.2": "<b>Drug Use:</b> Check the appropriate box to indicate whether the medicinal ingredient or combination of medicinal ingredients in respect of which the CSP is being sought is for human or veterinary use.",
    "ht.medic.1": "Medicinal Ingredient(s)",
    "ht.medic.2": "<b>Medicinal Ingredient(s):</b> Enter the medicinal ingredient or medicinal ingredients included in the specific drug product in the NDS set out in the CSP application. Please enter the medicinal ingredient or medicinal ingredients exactly as they appear on the NOC for that NDS. Applicants may view this information on Health Canada’s online NOC database, or they may request a copy of the NOC from Health Canada.",
    "ht.medic.3": "<b>Product Name:</b> Enter the product name (brand name) included in the NDS set out in the CSP application. Please enter the product name exactly as it appears on the NOC for that NDS. Applicants may view this information on Health Canada’s online NOC database, or they may request a copy of the NOC from Health Canada.",
    "ht.attes.1": "Attestations",
    "ht.attes.2": "See section 2.2.2 of the Guidance Document: Certificates of Supplementary Protection for additional details.",
    "ht.mark.app.1": "Date of first marketing approval application",
    "ht.mark.app.2": "<b>If applicable, please enter the date of submission of the first of those marketing approval applications and select the country of the first of those marketing approval applications. If the first of those marketing approval applications is a member of the European Union, please enter the name of the specific country.</b>",
    "ht.fee.1": "Fee Payment",
    "ht.fee.2": "<b>Fee payment and amount:</b> Please check the box and enter the fee amount. The fee must be paid in Canadian currency to the account of the Receiver General of Canada, according to section 9 of the Certificate of Supplementary Protection Regulations. Beginning April 1, 2018, the fee increases annually by an amount equal to 2% of the fee payable in the previous year, rounded up to the nearest dollar. Health Canada will publish the fee increase in the Canada Gazette Part I annually. An applicant may apply to the Minister for a CSP on the payment of the prescribed fee. One of the filing requirements for a CSP application is the receipt of a description of the method of payment used to pay the fee, which is provided to the Minister through the CSP application form. Anyone can pay the fee on behalf of the applicant. An agent must use the applicant’s CSP Customer Number when paying on behalf of the applicant.",
    "ht.fee.meth.1": "Method of Payment",
    "ht.fee.meth.2": "Select the method of payment used to pay the application fee in accordance with paragraph 6(3)(e) of the CSP Regulations from the drop-down list.",
    "ht.cert.1": "Certification",
    "ht.cert.2": "<b>Name of Authorized Official:</b> Provide the name of the person with the authority to make the attestations and certification on behalf of the applicant making the CSP application.",
    "ht.cert.3": "<b>Job Title:</b> Enter the job title of the person making the attestations and certification.",
    "ht.cert.4": "<b>Date:</b> Provide the date of the attestations and certification.",

    "billing.address": "Billing Address",
    "bill.add.check": " Select to enter a billing address that is different from the Applicant's Contact Information",
    "bill.add.org": "Organization Name (Full legal Name - no abbreviations)",
    "label.applicant": "Applicant Information",
    "label.billing": "Billing Address",

    "msg.success.load": "The file was loaded successfully",
    "msg.err.parseFail": "Error: there was an error parsing the working file.",
    "msg.err.jsonparse": "There was an error parsing the working file.",
    "msg.err.file.load": "There was a problem loading the file.",
    "msg.err.file.type": "Error: An invalid file type was selected.",
    "msg.err.form.type": "Error: the wrong form type was selected for this form.",
    "msg.err.checksum": "Error: there was an error parsing the file.",
    "DISCLAIMER":"The contents of this form may be publicly disclosed.",
    "save.working.copy": "Save Working Copy",
    "generate.final.internal": "Approve Final  XML",
    "generate.final.external": "Save Draft for Filing",
    "attestation.date.of.first.marketing.approval.application": "Date of first marketing approval application",
    "attestation.country.of.first.marketing.approval.application": "Country of first marketing approval application",
    "error.medic": "Medicinal Ingredient(s)",
    "error.fee": "Fee Payment",
    "error.cert.first": "Certification - First name",
    "error.cert.last": "Certification - Last name",
    "error.cert.job": "Certification - Job title",
    "error.cert.date": "Certification - Date",
    "public.disc": "The contents of this form may be publicly disclosed.",
    "error.msg.amount.limit":  "Must be less than 10,000,000"
}
